Ibex Biosciences, Inc. — Form D
Ibex Biosciences, Inc. of Rockville, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-07-15. The offering totals $5.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-15
- Form: D
- Accession: 0001798553-21-000002
- Industry: Biotechnology
- Exemptions: 04
- Total offering: $5.0M
- Amount sold: $1.0M
- Remaining: $4.0M
- Minimum investment: $25K
- Investors: 2
- Date of first sale: 2021-07-05
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-406382
Issuer
- Name: Ibex Biosciences, Inc.
- CIK: 0001798553
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 9610 Medical Center Drive, Rockville, MD, 20850
- Phone: 301-761-1500
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Roy Joseph Feinson | Director | Washington, DC |
| Alberto Murat Croci | Director | Chevy Chase, MD |
| Alberto Murat Croci | Executive Officer | Chevy Chase, MD |
| Michael Joseph Karlin | Director | Bethesda, MD |
| Michael Joseph Karlin | Executive Officer | Bethesda, MD |
| Sylvan Isaac Karlin | Director | Bethesda, MD |
Other filings by this issuer (3)
More